Table 2 Baseline characteristics of patients with initial Thy 2 nodules
All Patients with Initially Thy 2 Nodules N = 495 | Patients with Thy 2 Nodules that Underwent Repeat FNAB N = 206 | |
|---|---|---|
Age, Mean (± SD) years | 53.3 (14.4) | 52.8 (13.9) |
Female, N (%) | 429 (86.3) | 179 (86.1) |
Ethnicity, N (%) | ||
White | 478 (96.6) | 205 (98.6) |
Other | 6 (1.2) | 1 (0.5) |
Unknown | 11 (2.2) | 2 (1.0) |
Personal history of non-thyroidal cancer, N (%) | 9 (1.8) | 0 (0%) |
Baseline fT4, Mean (± SD) pmol/l | 11.1(3.2) | 11.1 (4.4) |
Baseline TSH, Median (± Min–Max) mIU/L | 1.1(0.01- 12.8) | 1.2 (0.01–12.8) |
Baseline thyroid status, N (%) | ||
Euthyroid | 370 (74.7) | 152 (73.1) |
Hyperthyroid | 4 (0.8) | 1 (0.5) |
Subclinical hyperthyroid | 13 (2.6) | 2 (1.0) |
Subclinical hypothyroid | 4 (0.8) | 2 (1.0) |
Follow-up, Mean (± SD) time months | 74.6(19.6) | 85.4 (14.2) |